Low molecular weight protein tyrosine phosphatases (LMW-PTPs) are an enzyme family that plays a key role in cell proliferation control by dephosphorylating/ inactivating both tyrosine kinase receptors (such as PDGF, insulin, and ephrin receptors) and docking proteins (such, as b-catenin) endowed with both adhesion and transcriptional activity. Besides being a frequent event in human tumors, overexpression of LMW-PTP has been recently demonstrated to be sufficient to induce neoplastic transformation. We recently demonstrated that overexpression of LMW-PTP strongly potentiates the stability of cell-cell contacts at the adherens junction level, which powerfully suggests that LMW-PTP may also contribute to cancer invasivity. Focusing on mechanisms by which LMW-PTP is involved in cancer onset and progression, the emerging picture is that LMW-PTP strongly increases fibronectin-mediated cell adhesion and mobility but, paradoxically, decreases cell proliferation. Nevertheless, LMW-PTP-transfected NIH3T3 fibroblasts engrafted in nude mice induce the onset of larger fibrosarcomas, which are endowed with higher proliferation activity as compared to mock-transfected controls. Quite opposite effects have been obtained with engrafted fibroblasts transfected with a dominant-negative form of LMW-PTP. Notably, in sarcoma extracts, LMW-PTP overexpression greatly influences the ephrin A2 (EphA2) but not PDGF receptor or b-catenin tyrosine phosphorylation. The high association of dephosphorylated EphA2 overexpression with most human cancers and our observation that cell growth stimulation by LMW-PTP overexpression is restricted to the in vivo model, strongly suggest that LMW-PTP oncogenic potential is mediated by its EphA2 tyrosine dephosphorylating activity.
Introduction
Protein tyrosine phosphorylation generates the powerful signals necessary for the growth, migration, and invasion of normal and malignant cells (van der Geer et al., 1994) . A number of tyrosine kinases have been associated with cancer progression (van der Geer et al., 1994; Cance and Liu, 1995) , and increased tyrosine kinase activity is a reliable marker of cancer progression (Lower et al., 1993; Kopreski et al., 1996) . Growing evidence indicates that the contribution of phosphotyrosine protein phosphatases (PTPs) to the control of cell phosphorylation is as relevant as that of protein tyrosine kinases. The PTPs superfamily is composed of almost 70 enzymes that, despite very limited sequence similarity, share a common CX 5 R active site motif and an identical catalytic mechanism. On the basis of their function, structure, and sequence, PTPs can be classified into four main families: (1) tyrosine-specific phosphatases, (2) VH1-like dual specificity PTPs, (3) cdc25, and (4) low molecular weight phosphatases (Zhang, 2001) .
Low molecular weight protein tyrosine phosphatases (LMW-PTP) are a group of 18-kDa enzymes that are widely expressed . LMW-PTP has been shown to interact with several receptor tyrosine kinases and docking proteins, including platelet-derived growth factor receptor (PDGF-R) (Chiarugi et al., 1995) , ephrin A2 receptor (Eph2A) (Kikawa et al., 2002) , and b-catenin (Taddei et al., 2002) . LMW-PTP has been largely considered a negative regulator of growth factor-induced cell proliferation, although in some instances it functions as a positive device. For example, in v-Ha-Ras-transformed cells, LMW-PTP increases the cell proliferation rate (Ramponi and Stefani, 1997) . Recently, Park et al. presented evidence that Xenopus laevis LMW-PTP is a functional component of the fibroblast growth factor receptor-1 complex and acts as a positive regulator of the Ras MAP kinase pathway. In addition, using a loss-of-function strategy employing antisense morpholino oligonucleotides, they revealed that Xenopus laevis LMW-PTP is required for fibroblast growth factor-induced mesoderm formation in ectodermal explants and during embryogenesis (Park et al., 2002) . LMW-PTP has also been indicated as a positive regulator in the Eph receptor system, in which the recruitment of LMW-PTP to Eph receptor complexes was shown to be important for promotion of endothelial capillary-like assembly and cell adhesion (Stein et al., 1998) . Mutation of the LMW-PTP binding site in Eph B1 causes failure of endothelial cells to adhere to fibronectin, suggesting that the interaction of LMW-PTP with Eph B1 may be necessary for cell adhesion and plays a positive role in this event (Stein et al., 1998) . Finally, the role of LMW-PTP in cell transformation has been investigated by Kikawa et al., reporting that LMW-PTP is overexpressed in many oncogene-transformed or tumor-derived mammary epithelial cells. In addition, the overexpression of LMW-PTP is sufficient to confer transformation in nontransformed epithelial cells and the oncogenic activity of LMW-PTP in mammary-derived cells requires EphA2 signaling (Kikawa et al., 2002) .
Our present studies concern the role of LMW-PTP during tumor onset and progression. We demonstrate that LMW-PTP, while negatively regulating growth factor-mediated proliferation in in vitro NIH3T3 cell cultures, is a positive regulator of tumor onset and growth in in vivo animal models. Despite the fact that LMW-PTP overexpressing cells are endowed with enhanced in vitro adhesion and mobility, their engrafts did not lead to metastasis. In addition, we demonstrate that the oncogenic function of LMW-PTP in fibrosarcoma progression is linked to EphA2 regulation.
Results

LMW-PTP controls cell proliferation and motility in vitro
Our main plan was to evaluate the influence of LMW-PTP on tumor onset and progression. The recent literature presents LMW-PTP as a phosphatase able to give both positive and negative signals on cell growth, obviously causing an ambiguous background about its physiological role. The first point that we addressed was the in vitro behavior of LMW-PTP overexpressing cells. Previously reported data on PDGF-induced mitogenesis indicated LMW-PTP as a negative regulator of cell proliferation, although it positively influences integrinmediated cell motility (Chiarugi et al., 1995 (Chiarugi et al., , 2000b Raugei et al., 2002) . In addition, very recently it has been reported that LMW-PTP increases cadherinmediated cell-cell adhesions, leading to adherens junction strengthening (Taddei et al., 2002) . In order to further examine the role of LMW-PTP on in vitro cell proliferation, motility, and apoptosis, we overexpressed wild-type (wt) LMW-PTP and its dominant-negative (dn) mutant, carrying the substitution of the catalytic Cys12 to Ser, in NIH3T3 cells. First, we analysed cytoskeleton motility of cells, either by fibronectincoated dishes adhesion assay (Figure 1a) or their ability to move towards chemoattractants in the serum using the Boyden chamber motility assay for 6 h (Figure 1b) , indicating that overexpression of wtLMW-PTP leads to a strong increase of cell motility. Notably, the overexpression of dnLMW-PTP causes the opposite effect. Second, we analysed the chemoinvasivity of LMW-PTP overexpressing cells by a Boyden chamber motility assay through the Matrigel support for 24 h (Figure 1c) , and by a wound-healing assay, in which cells are allowed to fill the gap for 24 h (Figure 1d ). Again the overexpression of wtLMW-PTP leads to a strong increase of both chemoinvasivity and the ability to fill the wound, while the dn mutant induces the opposite phenomenon. These results validate the positive role of LMW-PTP in the regulation of in vitro cell motility in response to serum, even through a physical barrier of reconstructed basal lamina or through a rapid colonization of the wound. In agreement with their ability to escape from the basal lamina, we demonstrate herein, by gelatin zymography assay, that wtLMW-PTP expressing cells show enhanced matrix metalloproteinases (MMPs) production ( Figure 1e) .
Second, to investigate the possibility that LMW-PTP overexpression causes autocrine effects on cell growth, we analysed the proliferation on standard untransfected NIH3T3 cells in conditioned media (supernatants of mock transfected, wt or dnLMW-PTP overexpressing cells). We did not find any difference in the growth rate of control cells in wt and dnLMW-PTP conditioned media, thus excluding the possibility of the generation by LMW-PTP overexpression of an autocrine loop affecting cell proliferation (Figure 2a) .
Third, since the enhanced apoptotic threshold, could favor tumor growth independently from cell proliferation rate by increasing cell survival (Borner, 1996; Evan and Vousden, 2001) , we also analysed the susceptibility to chemical hypoxia-induced apoptosis of wt and dnLMW-PTP overexpressing cells using the respiratory chain blocker Antimycin A as apoptotic stimulus. Our data (Figure 2b) show that the dnLMW-PTP expressing cells have a lower apoptotic threshold with respect to mock-transfected cells using 200 mM antimycin. Conversely, we observed only a slight decrease of the apoptotic susceptibility of wtLMW-PTP compared to mock-transfected cells.
The picture that emerges from all data both from literature and reported here, summarized in Table 1 , is that LMW-PTP negatively affects cell proliferation in response to serum and positively influences the adhesive and motility properties of cells, indicating that LMW-PTP may positively affect the attack and colonization of connective tissues.
LMW-PTP acts as a positive regulator of nude mice sarcoma onset
In the light of these results, we have analysed the role of LMW-PTP in in vivo tumor onset and progression. Because in vitro analyses of cell growth do not always predict the in vivo tumorigenic potential, we planned to implant wt and dnLMW-PTP overexpressing cells in athymic mice. Cells (1 Â 10 6 ) were subcutaneously inoculated into 30 nude mice (six per group) and caused the presence of palpable tumors within 4 weeks ( Figure 3a) . Surprisingly, our results show that wtLMW-PTP positively influences the formation of a primary sarcoma in mice, while dnLMW-PTP produces the opposite effect. In fact, mice inoculated with dnLMW-PTP expressing cells develop primary sarcomas with a great delay compared to mock-transfected cells. In addition to the rate of tumor onset, LMW-PTP influences the dimension of the tumor, as the median volume of resulting tumors was not related to the Cells were allowed to adhere to dishes in complete medium, scored with a micropipette tip, and photographed either immediately or after 24 h to visualize incoming cells. Images were acquired with a digital camera under a phase-contrast microscope. Panel (e) MMP expression: Cells of the indicated type were allowed to grow for 48 h in complete medium. The medium was collected and analysed for MMP activity by gelatin zymography. The result is a representative gel zymography; band intensities (proportional to the MMP activity on gelatin as substrate) were quantified from three independent experiments with densitometric analysis, and the mean7s. Figure 3b ). To confirm this indication, NIH3T3 cell growth in vivo was assessed by quantifying the expression of proliferating cell nuclear antigen (PCNA), a marker for actively dividing cells, including sarcoma cells (Albini et al., 2001; Liekens et al., 2001) . PCNA expression was evaluated by Western blot analysis using lysates from primary tumors from three randomly selected mice from each group (Figure 3c ). Normalization was achieved by antiactin immunoblot of the same lysates ( Figure 3d ). PCNA expression is perfectly correlated with the sarcoma growth rate and volume of cells expressing LMW-PTP, reinforcing the idea of a positive function of LMW-PTP in tumor onset.
To assess the in vivo invasiveness potential of LMW-PTP expressing cells, we checked for lung metastases in nude mice explants. The necropsy did not reveal any metastatic region in any of the analysed animals (n ¼ 30). This finding was further confirmed by injection of either wt or dnLMW-PTP expressing cells (n ¼ 15) in the tail vein of athymic mice. Again, we did not find any lung metastasis in animal explants.
These findings suggest a positive role of LMW-PTP in both tumor implantation and proliferation rate, but appear to exclude its involvement in the invasive capacity and metastasis formation.
EphA2 is the tyrosine phosphorylated substrate of LMW-PTP in developing sarcomas
To clarify the role of LMW-PTP as a positive regulator of tumor onset and growth, we analysed the tyrosine phosphorylation levels of several LMW-PTP substrates in developing sarcomas. LMW-PTP has been shown to interact with and dephosphorylate the PDGF-R, bcatenin, and EphA2 receptor (Chiarugi et al., 1995; Kikawa et al., 2002; Taddei et al., 2002) . First, we evaluated the tyrosine phosphorylation level of PDGF-R in primary tumors from wt and dnLMW-PTP expressing cells in the developing sarcomas (Figure 4a) . Surprisingly, our findings reveal that in the developing sarcomas the PDGF receptor was not a preferential LMW-PTP substrate. Neither wtLMW-PTP nor dnLMW-PTP overexpression affected the phosphotyrosine content of the PDGF receptor. In addition, the level of expression of PDGF receptor in sarcomas was very low in comparison to that of in vitro NIH3T3 cells before injection in mice (data not shown).
As an alternative possibility, we examined whether LMW-PTP affected the phosphotyrosine levels of the cytoplasmic pool of b-catenin in the same tumor (Figure 4b ). Tyrosine phosphorylation of bcatenin leads to the disruption of contact with Ecadherin, leading to an increase in the free, uncomplexed cytoplasmic pool of the protein (Muller et al., 1999) . Unlike the cadherin-associated b-catenin, the cytosolic b-catenin is known to be the sole pool that is tyrosine phosphorylated in the cell. Recent studies demonstrate that tyrosine phosphorylation of b-catenin is correlated with tumor formation and invasiveness (Sommers et al., 1994; Bonvini et al., 2001) . We have already reported that in in vitro NIH3T3 cells the level of cytoplasmic bcatenin is negatively influenced by LMW-PTP expression (Taddei et al., 2002) . Unexpectedly, in developing sarcomas (although deriving from the same in vitro cell line) neither the tyrosine phosphorylation level nor the content of cytoplasmic b-catenin is influenced by LMW-PTP overexpression (Figure 4b ). The possibility that EphA2 receptor could serve as a substrate for LMW-PTP in fibrosarcoma cells has been investigated. The tyrosine phosphorylation level of EphA2 receptor was evaluated in developing sarcomas (Figure 4c ). The results show that EphA2 tyrosine phosphorylation level was dramatically decreased by the overexpression of wtLMW-PTP, and enhanced by expression of dnLMW-PTP, as indicated by both straight Western blot and immunoprecipitation analyses, suggesting that EphA2 receptor may be a substrate of LMW-PTP in vivo. It should be noted that in in vitro cell cultures the level of EphA2 is almost undetectable (data not shown), while is greatly enhanced in in vivo tumor explants. Finally, it has been reported that the function of EphA2 in epithelial cells is regulated by E-cadherin expression (Zantek et al., 1999) and that the increases of E-cadherin in NIH3T3 induce the expression of EphA2 (Orsulic and Kemler 2000) . In this light, we have analysed the level of E-cadherin in NIH3T3 cells (either expressing wt or dnLMW-PTP) and in tumor extracts. Although we did not find detectable levels of E-cadherin in in vitro NIH3T3 cultures, we found high E-cadherin expression levels ( Figure 4d ) in tumor extracts. In particular, we observed a good correlation between E-cadherin and EphA2 expression level in wtLMW-PTP-derived tumors, showing increased expression of both proteins, and in dnLMW-PTP-derived tumors, showing the opposite phenomenon.
Altogether these data suggest that LMW-PTP may have in vivo and in vitro differential substrates, EphA2 being its preferential target in developing sarcomas and PDGF receptor and/or b-catenin in NIH3T3 in in vitro cultures.
Discussion
A popular paradigm suggests that a balance between tyrosine kinase and phosphatase activities determines the cellular levels of protein tyrosine phosphorylation and thereby governs cellular decisions regarding growth, survival, and invasiveness. This model predicts that tyrosine kinases are oncogenic, whereas tyrosine phosphatases negatively regulate neoplastic transformation. Although this paradigm has generally been sustained by the recognition of oncogenic tyrosine kinases, emerging evidence reveals a more complex interplay between tyrosine kinases and phosphatases. For example, CAAX-PTP has been recently implicated as an oncogene (Cates et al., 1996) . Moreover, the enzymatic activity of Src family kinases is released by RPTPa´-mediated dephosphorylation of critical tyrosine 527 (Cobb and Parsons, 1993; Liu and Pawson, 1994) .
There is a great abundance of biochemical findings concerning the in vitro LMW-PTP role, but its in vivo function is less understood. By means of wt and dnLMW-PTP overexpression, we and others suggest both negative and positive roles for LMW-PTP. In particular, in in vitro cell cultures LMW-PTP negatively influences PDGF-R (Chiarugi et al., 1995) , fibroblast growth factor receptor (Rigacci et al., 1999) , epidermal growth factor receptor (Ramponi et al., 1989) and insulin receptor signaling (Chiarugi et al., 1997) , and positively affects EphA2 (Kikawa et al., 2002) and EphB1 signaling (Stein et al., 1998) . Similar to LMW-PTP, SHP-2 has been proposed for both a positive and negative role in signal transduction (Ronnstrand and Heldin, 2001 ). For example, mutation of PDGF-R Tyr1009, namely the SHP2 binding site, impairs the downregulation of PDGF-R (Lechleider et al., 1993) , suggesting a negative role for this phosphatase. However, SHP-2 has also been shown to act as a positive component of PDGF signaling, where mutations in the SHP-2 binding sites inhibited chemotaxis and reduced PDGF-induced Ras and MAP kinase activation (Ronnstrand et al., 1999) . To note, an in vitro study has shown that LMW-PTP binds to and dephosphorylates a phosphopeptide containing Tyr1009 derived from PDGFR-b (Bucciantini et al., 1998) , suggesting that SHP-2 and LMW-PTP may share a common substrate. In addition, both SHP-2 and LMW-PTP have been shown to play a positive role in FGF-mediated mesoderm induction during Xenopus laevis development (O'Reilly et al., 2000; Park et al., 2002) .
To investigate the in vivo role of LMW-PTP, we analysed the effect of wt and dnLMW-PTP overexpres- (ii) the oncogenic potential of the phosphatase is linked to EphA2 and not to PDGF-R or b-catenin dephosphorylation. Our results strongly suggest that the same enzyme, namely a phosphotyrosine phosphatase, may have different in vivo and in vitro performances/ substrates. In particular, in vitro overexpression of wtLMW-PTP in NIH3T3 cells causes a strong reduction of proliferation in response to serum growth factors, together with an enhancement of both the adhesive properties of cells, that is integrin-and cadherinmediated cell adhesion, and cell motility, that is chemotaxis towards growth factors and the ability of wounds to regenerate. Conversely, engrafted LMW-PTP transfected/overexpressing NIH3T3 cells lead to the onset of larger and more numerous sarcomas compared to mock-transfected cells. Nevertheless, NIH3T3 overexpression does not affect the ability of primary tumors to form lung metastases. Cancer arises when a population of cells gain the ability to inappropriately grow and survive. These biological behaviors result from genetic and/or environmental abnormalities triggering specific signals and promoting cell proliferation and survival (Hunter, 2000) . Growing evidence from experimental and clinical studies points to the fundamental, pathophysiologic role of several factors in the growth of solid tumors, that is, (i) the self-production of growth factors which may sustain tumor growth, (ii) susceptibility to hypoxiamediated apoptosis which structurally and functionally disturbs microcirculation, causing deterioration of the diffusion geometry and tumor-associated anemia, (iii) alterations in the adhesive properties of tumor cells, often correlated to progression to tumor malignancy (Comoglio and Trusolino, 2002) . Our data suggest that the overexpression of LMW-PTP does not affect the autocrine capacity of NIH3T3 cells, thus excluding that the oncogenic potential of the phosphatase may be linked to growth factor overproduction. Conversely, it is implied that the effect of LMW-PTP on hypoxiamediated apoptosis may, to some extent, correlate with the positive effect of the phosphatase in tumor onset and progression. In regard to the third point, the phenotypic effect of LMW-PTP on cell adhesive properties appears to be quite remarkable, that is, LMW-PTP positively affects both cell-cell and/or cell-matrix adhesion. It is often reported that tumor cells show a decrease in cellcell and/or cell-matrix adhesion, although it is not known whether these alterations are causally involved in tumor progression or if they are only the epiphenomena of tumor cell phenotypic changes (Cavallaro and Christofori, 2001 ). In addition, the involvement of cadherin-mediated adherens junctions is well documented for the spreading of tumor cells from the primary site to distant organs and the dissemination of metastases (Beavon, 2000) . Conversely, besides tumor malignancy, the role of cell adhesion in the regulation of primary tumor onset and in the proliferation rate of cancer cells has not been strongly addressed. In this light, it is possible that the enhancement of the adhesive properties of cells leads to a facility in contacting the primary site of growing tumors. In this view, LMW-PTP may improve tumor implantation and growth, while not affecting the in vivo invasiveness properties of LMW-PTP overexpressing cells. In agreement with this speculation, wtLMW-PTP overexpressing cells are able to induce fibrosarcoma onset and growth but not its metastasis, despite the in vitro invasivity and MMP production induced by LMW-PTP overexpression. Indeed, metastasis is known to be the result of an intricate and coordinated interplay between different factors including cell adhesion, proteolysis, migration, angiogenesis, responsiveness to local growth, and survival factors (for a recent review see Comoglio et al., 2002) . Since a multitude of conditions must be exhaustively satisfied for metastasis onset, it is not surprising that LMW-PTP overexpression, although affecting cell motility and adhesion, is not able per se to complete this multistep process leading to metastatic spread.
Our data demonstrate that LMW-PTP may interact and dephosphorylate different substrates in vivo or in vitro. We previously reported that in in vitro NIH3T3 cells PDGF-R and b-catenin are efficiently dephosphorylated by the phosphatase, thus correlating with decreased PDGF-mediated proliferation rate and increased cadherin/b-catenin cell adhesion, respectively (Chiarugi et al., 1997; Taddei et al., 2002) . On the other hand, in fibrosarcomas neither PDGF-R nor b-catenin are dephosphorylated by LMW-PTP which is conversely active on EphA2 receptor. The EphA2 receptor is overexpressed in a large number of cancers, including breast, prostate, and lung carcinomas together with melanomas and sarcomas (Easty et al., 1995; Zelinski et al., 2001; Varelias et al., 2002) . In addition to its overexpression, EphA2 is functionally altered in transformed cells by regulating its tyrosine phosphorylation level. In particular, EphA2 is prominently tyrosine phosphorylated in nontransformed cells, while it is mainly dephosphorylated in transformed cells (Zantek et al., 1999 Zelinski et al., 2001) . LMW-PTP has already been reported to interact with EphA2 in epithelial cells cultured in vitro. In these cells, the overexpression of LMW-PTP is sufficient to confer transformation, the oncogenic activities of the phosphatase being dependent on altered EphA2 tyrosine phosphorylation (Kikawa et al., 2002) . In this context, our data underline that, in vivo, EphA2 dephosphorylation represents the main feature of LMW-PTP activity, likely attributing to PDGF-R and b-catenin dephosphorylation a role in different circumstances. We think that this behavior is mainly due to differences between in vivo and in vitro models and that the effect of a given protein, in this case a phosphatase, may vary depending upon the physiological circumstances and different substrata availability.
We stress that the EphA2 and E-cadherin expression levels in wtLMW-PTP and dnLMW-PTP developing sarcomas (Figure 4c and d) are correlated with their tumor onset and growth, in agreement with previously reported data showing that E-cadherin is directly required for EphA2 function (Orsulic and Kemler, 2000) . These observations further strengthen our idea of wtLMW-PTP as a positive regulator of cell transformation.
In addition to the rate of tumor onset, LMW-PTP influences the dimension of the tumor, as the median volume of resulting tumors is not related to the number of implanted cells. These findings indicate that in vivo LMW-PTP positively influences both the ability of transformed cells to adhere to the tumor primary site and their proliferation rate, as indicated by PCNA analysis. This is in agreement with the dephosphorylation of EphA2 by LMW-PTP in developing sarcomas. In fact, in contrast to other RTKs, activation and tyrosine phosphorylation of Eph receptors fails to promote cell proliferation (Brambilla et al., 1995; Bruce et al., 1999) , but initiates signaling pathways that exert antimitogenic functions. Hence, the LMW-PTPmediated EphA2 dephosphorylation leads to attenuation of antiproliferative activity, in agreement with recent studies showing that unphosphorylated EphA2 functions as a powerful oncoprotein (Zantek et al., 1999; Zelinski et al., 2001; Carles-Kinch et al., 2002) . Accordingly, Kikawa et al. (2002) reported that LMW-PTP-overexpressing MCF10A cells acquire a transformed phenotype when cultured in three-dimensional basement membrane, such as Matrigel, and gain the ability to colonize soft agar but show a reduced rate of monolayer cell growth. This is in agreement with the decreased growth rate we found in LMW-PTP overexpressing NIH3T3 fibroblasts (Chiarugi et al., 1995; Raugei et al., 2002) . Consistent with this, we underline that transformation of epithelial cells often leads to a decreased monolayer cell growth rate and that the most aggressive variants of them in vivo, show the slowest growth in monolayer cultures Zelinski et al., 2001) . These outcomes may have serious implications when using proliferation assays in nontransformed cell lines as predictive of transformed cell behavior.
In summary, our current studies recognize LMW-PTP as a positive regulator of tumor growth in vivo, linking the biochemical and biological actions of LMW-PTP to EphA2 dephosphorylation. We stressed that these findings have important significance as they definitely dislodge LMW-PTP from the negative PTP family. It is noteworthy that only two in vivo investigations out of many in vitro studies concerning LMW-PTP negative function, that is, this study and observations on Xenopus laevis development (Park et al., 2002) , are in agreement that LMW-PTP is a positive regulator.
Materials and methods
Cell lines and reagents
NIH3T3 were from ATCC. Monoclonal antibodies specific for proliferating cell nuclear antigen (PCNA) and b-catenin were purchased from Transduction Laboratories. Monoclonal antibodies specific for phosphotyrosine (4G10) and EphA2 (clone D7) were purchased from Upstate Biotechnology Inc. Polyclonal antibodies against LMW-PTP were prepared as described elsewhere (Chiarugi et al., 1995) .
Cell culture and transfections
NIH3T3 cells were routinely cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum in a 5% CO 2 humidified atmosphere. A measure of 10 mg of pRcCMV-wtLMW-PTP or pRcCMV-C12S-LMW-PTP 0 expressing the dn Cys-12 to Ser mutant of LMW-PTP (Chiarugi et al., 1995) were transfected in NIH3T3 cells using the calcium phosphate method. Stable transfected clonal cell lines were isolated by selection with G418 (400 mg/ml). For in vitro and in vivo studies, we selected two clones of NIH3T3 cells that equally express wtLMW-PTP (A and B) or dnLMW-PTP (A and B).
Immunoprecipitation and Western blot analysis NIH3T3 cells (1 Â 10 6 ) were seeded in 10-cm plates in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. Cells were serum-starved for 24 h before receiving 20% FCS. Cells were then lysed for 20 min on ice in 500 ml of RIPA lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Nonidet P-40, 2 mM EGTA, 1 mM sodium orthovanadate, 1 mM phenylmethanesulfonyl fluoride, 10 mg/ml aprotinin, and 10 mg/ml leupeptin). For the solid tumors, 100 mg of each sample was homogenized in lysis buffer with a Dounce homogenizer. Lysates were clarified by centrifugation and immunoprecipitated for 4 h at 41C with 1-2 mg of the specific antibodies. Immunocomplexes were collected on protein A-Sepharose, separated by SDS-PAGE, and transferred onto nitrocellulose. Immunoblots were incubated in 3% bovine serum albumin, 10 mM Tris-HCl, pH 7.5, 1 mM EDTA, and 0.1% Tween 20 for 1 h at room temperature, probed with specific antibodies and then with secondary antibodies conjugated with horseradish peroxidase, washed, and developed with the Enhanced Chemiluminescence kit.
Cell adhesion assay
Cell adhesion was assessed as described elsewhere (Chiarugi et al., 2000b) . Briefly, 3 Â 10 4 cells were serum starved for 24 h and then seeded for the indicated time in a 96-well dish precoated for 2 h with 10 mg/ml of human fibronectin and washed twice with PBS, in medium containing 20% FCS. Cell adhesion was stopped by removing the medium and by the addition of a 0.5% crystal violet solution in 20% methanol. After 5 min of staining, the fixed cells were washed with PBS and solubilized with 200 ml/well of 0.1 M sodium citrate, pH 4.2. The absorbance at 595 nm was evaluated using a microplate reader. All cell adhesion assays were performed in triplicate.
Cell motility and chemoinvasivity assays
Cell motility (Chiarugi et al., 2000b) and chemoinvasivity (Yagel et al., 1989) were assessed as described elsewhere. Briefly, migration of NIH-3T3 cells was assayed with the Transwell system of Costar, equipped with 8-mm pore polyvinylpyrrolidone-free polycarbonate filters (diameter, 13 mm) precoated with human type I collagen (20 mg/ml) and placed between the chemoattractant (lower chamber) and the upper chamber. The lower chamber was filled with medium supplemented with 20% FCS. Serum-free medium cultured cells were suspended by trypsinization, and 1.5 Â 10 5 cells in 200 ml were added to the top wells and incubated at 371C in 5% CO 2 for 6 h. After incubation, the cells attached to the upper side but not migrated through the filter were mechanically removed using cotton swabs. For the in vitro invasion assay chambers were prepared at 1 : 2 dilution of Matrigel (Becton Dickinson). Cells (5 Â 10 4 ) were loaded on top of the Matrigel layer for 24 h at 371C. The filters were fixed in 96% methanol and stained with Diff Quick staining solutions. Chemotaxis or chemoinvasivity were evaluated by counting the cells that had migrated to the lower surface of the polycarbonate filters. The number of cells in six randomly chosen fields was determined for each filter, and the counts were averaged (mean7s.d.).
Autocrine cell growth assay
NIH-3T3 cells (2 Â 10 4 ) were seeded in 24-multiwell plates and serum starved for 24 h before receiving conditioned media from 48 h subcultured mock transfected, wt and dn overexpressing cells. Fresh conditioned medium was added daily for 3 days. Cellular growth was stopped by removing the medium and by the addition of a 0.5% crystal violet solution in 20% methanol. After 5 min of staining the fixed cells were washed with PBS and solubilized with 200 ml/well of 0.1 M sodium citrate, pH 4.2. The absorbance at 595 nm was evaluated using a microplate reader.
Quantification of cumulative apoptotic events
The respiratory chain blocker Antimycin A was used at a concentration of 200 mM, previously reported to commit cells to apoptosis (Formigli et al., 2000) . The cumulative apoptotic events were scored for 72 h by the time-lapse videomicroscopy using a Zeiss inverted phase-contrast microscope equipped with a Â 10 objective, Panasonic CCD cameras, and JVC BR9030 time-lapse video recorders (Papucci et al., 2002) . After cell detachment from the substrate, apoptotic deaths were counted the moment the cell became fully shrunken and blebbing started.
Zymography
Metalloprotease zymography was assessed as described elsewhere, with minor modifications (Chiarugi et al., 2000b) . Briefly, culture medium from confluent cell monolayers was collected, and 20 ml was added to Laemmli sample buffer and run on an 8% SDS gel containing 0.1% gelatin. After electrophoresis the gel was washed twice with 2.5% Triton X-100 and once with reaction buffer (50 mM Tris-HCl, pH 7.5, 200 mM NaCl, 5 mM CaCl 2 . The gel was incubated overnight at 371C with freshly added reaction buffer and stained with Laemmli Coomassie blue solution.
Wound-healing assay
Cells were seeded in 10% FCS in culture dishes coated with 25 mg/ml fibronectin. After 4 h of incubation, dishes were scored with a sterile 200-ml micropipette tip and photographed. After 24 h, the wounds were photographed again to visualize incoming cells.
Tumorigenicity assay
Tumorigenicity was assayed by injection of 10 5 cells into nude mice (NIH nu/nu, female, and 6 weeks of age) subcutaneously over the lateral thorax. Animals were examined twice weekly and killed 7 weeks later. Lung metastases and the neoplastic nature of local tumors were confirmed by histologic examination.
